BioSante completes direct public offering

BioSante Pharmaceuticals Inc. (NASDAQ:BPAX), Lincolnshire, Ill. Business: Drug delivery, Endocrine/Metabolic, Genitourinary Date completed: 8/20/12 Type: Direct public offering Raised: $3.5 million Un...